TrialInternational immunopharmacology2021

Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial.

Payam Tabarsi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.